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Abstract Salivary bypass tubes (SBT) are increasingly
used to prevent pharyngocutaneous fistula (PCF) following
laryngectomy and pharyngolaryngectomy. There is minimal
evidence as to their efficacy and literature is limited. The aim
of the study was to determine if SBT prevent PCF. The study
was a multicentre retrospective case control series (level of
evidence 3b). Patients who underwent laryngectomy or
pharyngolaryngectomy for cancer or following cancer
treatment between 2011 and 2014 were included in the
study. The primary outcome was development of a PCF.
Other variables recorded were age, sex, prior radiotherapy or
chemoradiotherapy, prior tracheostomy, type of procedure,
concurrent neck dissection, use of flap reconstruction, use of
prophylactic antibiotics, the suture material used for the
anastomosis, tumour T stage, histological margins, day one
post-operative haemoglobin and whether a salivary bypass
tube was used. Univariate and multivariate analysis were
performed. A total of 199 patients were included and 24
received salivary bypass tubes. Fistula rates were 8.3% in the
SBT group (2/24) and 24.6% in the control group (43/175).
This was not statistically significant on univariate (p value
0.115) or multivariate analysis (p value 0.076). In addition,
no other co-variables were found to be significant. No group
has proven a benefit of salivary bypass tubes on multivariate
analysis. The study was limited by a small case group,
variations in tube duration and subjects given a tube may
have been identified as high risk of fistula. Further
prospective studies are warranted prior to recommendation
of salivary bypass tubes following laryngectomy.
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Introduction
Pharyngocutaneous fistulae (PCF) are the most common
serious complication following total laryngectomy or
pharyngolaryngectomy [1, 2]. The incidence of PCF is
reported to be between 3 and 65% [3–8] and they have
been estimated to cost one Canadian centre around
$400,000 a year [5].
Some units now advocate the use of salivary bypass
tubes (SBT) following laryngectomy to minimise the
chance of developing a PCF. However, the evidence base
for the use of SBT is limited. Literature is descriptive with
the exception of three studies. Two are retrospective single
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centre studies where univariate analysis was used to
determine an association between PCF and SBTs [9, 10].
The third, a multicentre retrospective study suggested a
benefit of salivary bypass tubes on univariate analysis, but
lacked statistical power for multivariate analysis, and
therefore, failed to show an independent effect [11].
Given the high potential for morbidity and even mor-
tality related to PCF, all efforts should be taken to prevent
this complication. The aim of this study was to analyse
factors associated with PCF following laryngectomy or
pharyngolaryngectomy in a cohort large enough to allow
multivariate analysis.
Materials and methods
The study was performed as part of a Master’s degree at the
Anglia Ruskin University. It is a retrospective case control
analysis. Patients who underwent a laryngectomy or
pharyngolaryngectomy following diagnosis or treatment of
laryngeal cancer or pharyngeal cancer involving the larynx
from the 1st of January 2011 until the 31st of December 2014
were included in the study. The University Faculty Research
Ethics Panel was consulted and approval for the study was
obtained provided individual NHS trust research and
development (R&D) departments gave approval. Seven head
and neck departments in the South East of England were
invited to participate and all agreed to contribute. Research
Ethics Committee Proportionate Review was granted via the
online Integrated Research Applications System and indi-
vidual NHS trust R&D departments were contacted to secure
relevant permissions which were all obtained.
Patients were identified through head and neck multi-
disciplinary team meetings and theatre logbooks. Patient
notes were reviewed to collect data including age, sex,
prior radiotherapy or chemoradiotherapy, prior tra-
cheostomy, type of procedure (laryngectomy or pharyn-
golaryngectomy), concurrent neck dissection (unilateral or
bilateral), use of flap reconstruction, use of prophylactic
antibiotics (for 72 h or more), suture material used for the
anastomosis, tumour T stage (as per histological specimen
during the resection except for patients who received a
laryngectomy for a dysfunctional larynx where the original
tumour T stage was used and this was recorded from
imaging and clinical examination findings), histological
margins (R0, R1 or R2), day one post-operative hae-
moglobin, whether a salivary bypass tube was used and
whether the patient developed a PCF.
Data was analysed using univariate and multivariate
analysis on the computer programme R from the R Foun-
dation for Statistical Computing. Binary and nominal data
was analysed using the Fisher’s exact Test to generate
p values for potential predictors of post-operative fistula
independently of the influence of co-variables. Continuous
variables were analysed with permutation tests using the
Monte Carlo algorithm. Standard errors and 95% Confi-
dence intervals were generated by bootstrap methodology.
Standard deviations are based on group data rather than
pooled estimates; however, standard errors of differences
between 95% confidence intervals were generated with
9999 bootstrap samples and p values obtained with 10,000
permutation samples. The type of flap was excluded from
statistical analysis due to the relatively small numbers in
the large number of different groups and potential combi-
nations of the variables.
Multivariate analysis is a correlation study and aims to
assess the relationship between variables. It relies on the
sample being random; otherwise there is a risk of bias. The
relationship between the presence and absence of post-
operative fistula was assessed using multiple predictor
binary logistical regression models with 13 variables as
potential predictive factors. Multivariate logistic models
were fitted with an algorithm package followed by a pre-
dictor selection algorithm. The model was then fitted with
penalised maximum likelihood estimations. A Receiver-
Operator Characteristic (ROC) curve was generated to
assess whether the model is a good predictor of the
occurrence of post-operative fistulae.
Results
(i) Summary of data.
All head and neck centres invited to take part provided data
for the study. A total of 271 patients were initially identi-
fied. There were 72 exclusions resulting in a total of 199
patients used for statistical analysis. Reasons for exclusions
included incomplete data and missing notes (44 patients),
incorrectly coded patients who had different surgery (23
patients), patients having a laryngectomy without a history
of malignancy (2 patients) and patients from the incorrect
time period (3 patients). Five laryngectomies were per-
formed for a dysfunctional larynx following previous
radiotherapy or chemoradiotherapy. For the purposes of
analysis these patients were assigned their original T stage
(one T1, three T2 and one T3 tumour).
The median patient age was 66 years (range
36–89 years). There were 32 (16%) female and 167 (86%)
male subjects. A total of 142 (71%) patients had a laryn-
gectomy while a further 57 (29%) underwent pharyngola-
ryngectomy. Previous radiotherapy or chemoradiotherapy
had been performed in 96 patients meaning 48% of patients
were having salvage surgery with 103 (52%) patients
undergoing primary surgery. Pre-operative tracheostomy
was performed in 43 (22%) patients. A total of 147 (74%)
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patients underwent concurrent neck dissection. Post-oper-
ative haemoglobin ranged from 5.3 to 14.6 g/dl with a
median of 10.0 g/dl. Vicryl was the most commonly used
suture type in 175 (88%) procedures. Alternative suture
material included vicryl rapide in three patients (2%),
polydioxanone (PDS) in 17 patients (9%) and staples in
four patients (2%). Tumour T stage ranged from T1 to T4
with 10 (5%) T1 tumours, 14 (7%) T2 tumours, 44 (22%)
T3 tumours and 131 (66%) T4 tumours (T4a and T4b
subgroups were combined). Histological margins were
positive (R1 or R2) in 42 (21%) patients and negative (R0
or negative due to no malignant disease) in the remaining
157 (79%) patients. Post-operative antibiotics were given
in 134 (67.3%) cases and reconstructive flaps were used in
62 (31%). Reconstructive flaps used included 31 (50%)
pectoralis major, 15 (24%) anterolateral thigh flap (ALT), 8
(13%) jejunal free flaps, five (8%) radial forearm free flaps
and two (2%) had a combination of a pectoralis major flap
with a free flap. Twenty-four patients (12%) had salivary
bypass tube inserted during surgery.
A total of 45 fistulae developed in the early post-oper-
ative period, an incidence of 23%. However, in the group
treated with a SBT only two post-operative fistulae
developed (8%) compared to 26% in the control group.
Table 1 shows the co-variables in the primary outcome
group (patients who received a salivary bypass tube)
compared to the control group. The descriptive statistics of
the group as a whole and stratified by the use of a SBT are
also shown in Table 1.
(ii) Univariate analysis.
No individual risk factor was associated with post-opera-
tive fistula. No p value from Fisher’s exact test or permu-
tation testing reached statistical significance of less than
0.05. The p values for Fisher’s exact test are summarised in
Table 1 and the values from the quantitative variables
which underwent permutation testing to generate p values
and the results are summarised in Table 2.
The salivary bypass tube groups were compared to see if
the patients receiving SBT were comparable using Fisher’s
exact test and permutation testing. The proportion of patients
who had a salivary bypass tubewere significantlymore likely
to have had a flap reconstruction (p = 0.017) and signifi-
cantly less likely to have had a tracheostomy (p = 0.003).
All other variables were found to be insignificant.
(iii) Multivariate analysis.
The predictors collected were analysed in the search algo-
rithm and the results of the binary logistic regression analysis
are shown in Table 3 and the results usingmultiple-predictor
binary logistical regression with fitted penalised maximum
likelihood estimations are shown in Table 4.
No co-variable was found to be significant in either the
binary logistic regression model or multiple-predictor
binary logistic regression model. In both models the closest
co-variable to significance was the SBT with p values of
0.076 (odds ratio 0.338, 95% confidence intervals 0.066,
1.108) and 0.057 (odds ratio 0.314, 95% confidence
interval 0.061–1.035), respectively.
The binary logistic regression model must be tested to
assess whether it is a good predictor for the occurrence of
post-operative fistula and this is done by considering the
ROC curve which is shown in Fig. 1. The area under the
ROC curve (AUC) is 0.629 (95% CI 0.535–0.719) and is a
measure of the models predictive performance. A value of
0.5 represents no predictive value and 1 perfect prediction.
A value of 0.629 was achieved and this suggests the model
has a moderate predictive performance.
Discussion
Pharyngocutaneous fistulae are multifactorial in their ori-
gin [12] and there is a large amount of literature on the
various causes. However, two systematic reviews have
highlighted a lack of good quality research [8, 13].
Numerous potential risk factors have been identified but
evidence to support which factors are significant is lacking
due to small studies and the number of potential variables
involved [8, 12].
Various factors have been associated with fistula
development including suture material [14, 15], surgical
experience [16] and the use of metronidazole [17, 18].
Patient co-morbidities are consistently identified as a sig-
nificant risk factor [2, 8, 12, 19, 20]. A systematic review
and meta-analysis by Paydarfar and Birkmeyer [8] found
prior tracheostomy, pre-operative radiotherapy, a low post-
operative haemoglobin and concurrent neck dissection to
be associated with higher rates of PCF [8]. The effect of
radiotherapy has been confirmed in a more recent sys-
tematic review and meta-analysis which failed to find a
difference between chemoradiotherapy and radiotherapy
groups; however, they did confirm flap reconstruction helps
prevent PCF [13]. Prior radiotherapy is associated with an
increased risk of PCF of 2.6 times [21]. In addition, fistulae
seen in the salvage setting are larger than those seen fol-
lowing primary surgery [6].
There are numerous other suggested causes for PCF but
they are disputed amongst groups. These include age
[22, 23], positive histological margins [23–25], suture
material [2, 12, 26], primary voice puncture [27–29], oral
feeding [30], type of pharyngeal closure [19, 26, 31, 32].
The antibiotics given and their duration depending on the
centre [33] but there is no clear evidence for any specific
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antibiotic regime [34] although clindamycin has been
shown to increase complication rates [35].
Most fistulae will heal spontaneously but some take
significantly longer, potentially requiring multidisciplinary
team input and on occasion complex additional surgery [4].
Saliva coming into contact with the wound edges [36] and
passing through the fistula defect are thought to be the
cause of delayed closure [36, 37]. Saliva in contact with the
wound leads to infection and micro-venous thrombosis
resulting in tissue damage and destruction [12]. They delay
post-operative oral feeding [4], increase inpatient hospital
stay, morbidity and patient anxiety [2, 3, 8] and are
Table 1 A summary of co-variables in the salivary bypass group compared to the control group cohort demographics, and fistula incidence with
univariate statistical analysis
Co-variant Number of
patients
Salivary Bypass
Tube Group
No Salivary
Bypass Tube
Post-operative
fistula
No post-
operative fistula
Fisher exact test
(p value)
n = 199 n = 24 n = 175 n = 45 n = 154
Sex
Male 167 (83.9%) 21 (87.5%) 146 (83.4%) 37 (82.2%) 130 (84.4%) 0.818
Female 32 (16.1%) 3 (12.5%) 29 (16.6%) 8 (17.8%) 24 (15.6%)
Type of surgery
Laryngectomy 142 (71.4%) 16 (66.7%) 126 (72.0%) 35 (77.8%) 107 (69.5%) 0.350
Pharyngolaryngectomy 57 (28.6%) 8 (33.3%) 49 (28.0%) 10 (22.2%) 47 (30.5%)
Radiotherapy or chemoradiotherapy
Yes 96 (48.2%) 13 (54.2%) 83 (47.4%) 20 (44.4%) 76 (49.4%) 0.613
No 103 (51.8%) 11 (45.8%) 92 (52.6%) 25 (65.6%) 78 (50.6%)
Previous tracheostomy
Yes 43 (21.6%) 0 (0%) 43 (24.6%) 11 (24.4%) 32 (20.8%) 0.681
No 156 (78.4%) 24 (100%) 132 (75.4%) 34 (75.6%) 122 (79.2%)
Tumour T stage
T1 10 (5.0%) 2 (8.3%) 8 (4.6%) 3 (6.7%) 7 (4.5%) 0.185
T2 14 (7.0%) 3 (12.5%) 11 (6.3%) 6 (13.3%) 8 (5.2%)
T3 44 (22.1%) 6 (25%) 38 (21.7%) 7 (15.6%) 37 (24.0%)
T4 131 (65.8%) 13 (54.2%) 118 (67.4%) 29 (64.4%) 102 (66.2%)
Positive margins on histology
Yes 42 (21.1%) 5 (20.8%) 37 (21.1%) 10 (22.2%) 32 (20.8%) 0.837
No 157 (78.9%) 19 (78.2%) 138 (78.9%) 35 (77.8%) 122 (79.2%)
Concurrent neck dissection
Yes 147 (73.9%) 16 (66.7%) 131 (74.9%) 30 (66.7%) 117 (76%) 0.248
No 52 (26.1%) 8 (33.3%) 44 (25.1%) 15 (33.3%) 37 (24.0%)
Prophylactic antibiotics
Yes 134 (67.3%) 17 (70.8%) 117 (66.9%) 27 (60%) 107 (69.5%) 0.279
No 65 (32.7%) 7 (29.2%) 58 (33.1%) 18 (40%) 47 (30.5%)
Reconstructive flap
Yes 62 (31.2%) 13 (54.2%) 49 (28.0%) 15 (33.3%) 47 (30.5%) 0.718
No 137 (68.8%) 11 (45.8%) 126 (72.0%) 30 (66.7%) 107 (69.5%)
Salivary bypass tube inserted
Yes 24 (12.1%) 24 (100%) 0 (0%) 2 (4.4%) 22 (14.3%) 0.115
No 175 (87.9%) 0 (0%) 175 (100%) 43 (95.6%) 132 (85.7%)
Age range, years 36–89 36–86 41–89 45–89 36–88 –
Post-operative
haemoglobin range, g/dl
5.3–14.6 7.1–13.9 5.3–14.6 7.4–13.0 5.3–14.6 –
Fistula developed
Yes 45 (22.6%) 2 (8.3%) 43 (24.6%) 45 (22.6%) 154 (77.4%) –
No 154 (77.4%) 22 (91.7%) 132 (75.4%) –
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associated with reduced quality of life [4]. Long-term
complications include secondary dysphagia from fibrosis
[12], and pharyngeal stenosis with potential requirements
for further surgery to dilate strictures and or excise ste-
nosed neopharynx with flap reconstruction [38].
Anecdotal evidence suggests SBT benefit patients
[13, 39, 40] and reduce costs [10]. They were first descri-
bed as a therapy for the prevention of PCF and stricture
formation in 1978 [41]. The tubes are designed to divert
solids and liquids which pass from the mouth to the
oesophagus away from the anastomosis [42]. In addition,
they are designed to prevent tube displacement into the
throat and reflux of stomach contents and yet be large
enough to allow oral feeding [42]. The SBT is made of
non-adherent silicone and comes in various sizes up to
20 mm [36, 37]. It is shaped like a funnel and sits against
the tongue base to channel saliva around the fistula and
suture line theoretically promoting healing and fistula
closure [36, 37]. Suturing the tubes to the tongue base [36]
or through transcutaneous sutures [43] has been described
to help secure them in place. Patients tolerate the tubes well
although they are mainly used as a treatment for existing
fistulae rather than in an attempt to prevent fistula devel-
opment [44]. SBT’s are generally inserted and removed
under a general anaesthetic [45] although local anaesthetic
techniques have been described for insertion [46] and
removal [9, 36]. Serious complications from pharyngeal
SBT are rare but have been described as a direct result of
their use. One patient developed peritonitis and went on to
die following migration of the tube into the ileum [47] and
arterio-esophageal fistulas have been described, one of
which was fatal [48, 49]. However, they are generally safe
with only mild complications such as discomfort and
granulation tissue formation [43]. Although in theory, early
oral intake may be possible, most surgeons prefer to feed
patients via a nasogastric tube placed through the SBT in
the early post-laryngectomy period [36].
An early study by Leon et al. [10] looked at 51
patient complications following pharyngolaryngectomy,
neck dissection and pectoralis major flap for advanced
cancer. They found no significant difference in compli-
cation rates between the SBT group and controls
including PCF [10]. Their fistula rates were generally
high at 47.4% in the SBT group and 60.9% in patients
without a tube. Patient numbers were small, limiting the
conclusions that could be drawn from this study, how-
ever, patients with SBTs spent less time in hospital, had
a reduction in the severity of complications with less
severe fistulas [10].
A univariate analysis by Bondi et al. [9] which exam-
ined the rate of PCF in matched patients with advanced
tumour stages with and without a SBT found a fistula rate
of 9% in the SBT group. Univariate analysis using the Chi-
squared test showed a significant benefit of the salivary
bypass tube in reducing fistula rates. No multivariate
analysis was performed [9].
Punthakee et al. [11] performed a multicentre study with
multivariate analysis on a sample 103 patients who had flap
reconstruction, of which 54 patients had salivary bypass
tubes inserted with a fistula rate of 7.4% [11]. Their uni-
variate analysis showed a statistically significant associa-
tion between lower rates of PCF and both flap
reconstruction and salivary bypass tubes [11]. Unfortu-
nately, their sample was not large enough to power the
multivariate statistical analysis [11]. So an independent
effect of SBT could not be confirmed.
The overall rate of PCF in our study of 22.6% is
similar to the literature which quotes rates of between 3
and 65% [3–8, 26]. The falling rates of fistula following
laryngectomy and lack of any statistically significant
variable may be partly due to the introduction of IMRT
and the MDT approach to surgery with better pre and
post-operative care and identification of those at higher
risk of fistula such as salvage cases receiving appropriate
treatment strategies. In this study, no variables were
found to be statistically significantly associated with PCF
even those identified in previous studies such as
radiotherapy.
Table 2 Univariate statistical analysis of continuous variables using 10,000 permutations and 9999 bootstrap calculations
Continuous variables Range Median Mean Standard deviation Standard error 95% confidence limits p value
Lower Upper
Age (years)
Yes 45–89 67 66.2 10.49 10.50
(59.0–74.0)
[45.0–89.0]
-3.7 3.0 0.877
No 36–88 66 65.9 9.78
Total 36–89 66 66.0 9.91
Post-operative haemoglobin (g/dl)
Yes 7.4–13.0 10 10.02 1.400 1.400
(8.9–11.1)
[7.4–13.0]
-0.06 0.93 0.142
No 5.3–14.6 10.2 10.45 1.784
Total 5.3–14.6 10.2 10.36 1.712
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The incidence of PCF in the group with a SBT was 8%
(occurring in 2 out of the 24 patients). This compares well
with other studies in the literature which records fistula
rates in patients with SBT at between 0 and 21.8%
[9–11, 37, 50]. We observed a difference in PCF rates in
those patients who had a SBT versus those who did not (8.3
versus 24.6%) however, this failed to reach statistical
significance.
There was a statistically significant association (on
univariate analysis) between the use of salivary bypass
tubes and free flap reconstruction. This may be explained
by patient selection, as clinicians who have identified
patients receiving a flap as high risk and used the SBT as
added protection against a fistula and/or to help create a
functioning pharynx and prevent stenosis in the flap
reconstruction group.
Table 3 Binary logistic regression model results of response variable presence of post-operative fistulae related to single predictors
Predictor Category n Presence of post-operative fistulae Odds ratio (95% confidence limits) p value
No, n = 154 Yes, n = 45
Sex Overall 199 154 (77.4%) 45 (22.6%) 0.671
Female 32 24 (75.0%) 8 (25.0%) 1.000
Male 167 130 (77.8%) 37 (22.2%) 0.828 (0.361, 2.056) 0.671
Age at admission (years) _ 199 1.003 (0.970, 1.037) 0.860
Laryngectomy or
pharyngolaryngectomy
Overall 199 154 (77.4%) 45 (22.6%) 0.296
Laryngectomy 142 107 (75.4%) 35 (24.6%) 1.000
Pharyngolaryngectomy 57 47 (82.5%) 10 (17.5%) 0.669 (0.298, 1.405) 0.296
Previous RT or chemo RT Overall 199 154 (77.4%) 45 (22.6%) 0.568
No 103 78 (75.7%) 25 (24.3%) 1.000
Yes 96 76 (79.2%) 20 (20.8%) 0.825 (0.423, 1.595) 0.568
Previous tracheostomy Overall 199 154 (77.4%) 45 (22.6%) 0.566
No 156 122 (78.2%) 34 (21.8%) 1.000
Yes 43 32 (74.4%) 11 (25.6%) 1.256 (0.563, 2.667) 0.566
Concurrent neck
dissection
Overall 199 154 (77.4%) 45 (22.6%) 0.207
No 52 37 (71.2%) 15 (28.8%) 1.000
Yes 147 117 (79.6%) 30 (20.4%) 0.628 (0.310, 1.302) 0.207
Post-operative Hb (g/dl) _ 199 0.862 (0.700, 1.049) 0.141
Suture type used for
anastomosis
Overall 199 154 (77.4%) 45 (22.6%) 0.371
PDS 17 13 (76.5%) 4 (23.5%) 1.000
Rapide 3 1 (33.3%) 2 (66.7%) 5.000 (0.526, 66.878) 0.159
Staples 4 3 (75.0%) 1 (25.0%) 1.286 (0.104, 10.799) 0.824
Vicryl 175 137 (78.3%) 38 (21.7%) 0.840 (0.290, 2.896) 0.764
Tumour T stage Overall 199 154 (77.4%) 45 (22.6%) 0.204
T1 10 7 (70.0%) 3 (30.0%) 1.000
T2 14 8 (57.1%) 6 (42.9%) 1.639 (0.329, 9.096) 0.549
T3 44 37 (84.1%) 7 (15.9%) 0.429 (0.098, 2.093) 0.278
T4 131 102 (77.9%) 29 (22.1%) 0.617 (0.171, 2.670) 0.489
Positive margins on
specimen
Overall 199 154 (77.4%) 45 (22.6%) 0.788
No 157 122 (77.7%) 35 (22.3%) 1.000
Yes 42 32 (76.2%) 10 (23.8%) 1.115 (0.488, 2.400) 0.788
Prophylactic antibiotic
cover given to prevent
fistula
Overall 199 154 (77.4%) 45 (22.6%) 0.230
No 65 47 (72.3%) 18 (27.7%) 1.000
Yes 134 107 (79.9%) 27 (20.1%) 0.657 (0.334, 1.311) 0.230
Salivary bypass tube
inserted
Overall 199 154 (77.4%) 45 (22.6%) 0.076
No 175 132 (75.4%) 43 (24.6%) 1.000
Yes 24 22 (91.7%) 2 (8.3%) 0.338 (0.066, 1.108) 0.076
Reconstructive flap used Overall 199 154 (77.4%) 45 (22.6%) 0.697
No 137 107 (78.1%) 30 (21.9%) 1.000
Yes 62 47 (75.8%) 15 (24.2%) 1.150 (0.561, 2.293) 0.697
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Limitations
Limitations of our study include its retrospective nature
which may lead to bias in patients who receive the sali-
vary bypass tube, with those who require more invasive
surgery tending to be selected for SBT. However, it
should be noted that when studying rare conditions ret-
rospective analysis is usually the only study design option
[51] and the results of well-designed retrospective studies
usually agree with prospective studies [52]. Furthermore,
there are potential observable and unobservable risk fac-
tors for PCF which are not included in this study and may
be having a significant effect on results. It is likely that
some surgeons reserve SBT for the patients perceived to
be at highest risk of fistulae which may confound results.
There was a statistically significant chance patients who
received a flap reconstruction would receive a SBT
(although this may be due to the low number of patients
who received a SBT). This potential bias in patient
selection cannot be completely excluded, however; we
have attempted to address the issue of bias with the
inclusion of multivariate analysis.
Conclusions
In this study, which is the first to include sufficient numbers
to allow multivariable analysis, we did not find an asso-
ciation between SBT and a reduction in PCF following
total laryngectomy or pharyngolaryngectomy. We would
recommend further research into salivary bypass tubes with
a larger cohort of patients receiving a SBT or a prospective
study design to increase understanding of their role in
pharyngocutaneous fistulae. Despite the limitations of ret-
rospective analysis our results suggest that any potential
benefit is at most modest and as such the routine use of
SBT cannot be recommended and surgeons must consider
their use on a case by case basis.
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